Our programs seek to ameliorate disease by translating cutting edge discoveries into new medicines. Zealous Therapeutics is developing multiple first-in-class therapeutic programs and will build on partnerships around its platform to establish a rich pipeline across several indications. Zealous Therapeutics employs a target based approach on specific diseases and applications.
We have a diverse portfolio of programs ranging from cancer metastasis, solid tumors and Immunology and inflammatory disorders. Zealous Therapeutics has developed Platform applicable to drug candidate, generating patentable NCEs addressing physico-chemical and pharmacological properties.
Developing alliances and partnerships is an integral part of Zealous Therapeutics corporate strategy. Zealous Therapeutics is committed to partnering with leading academics, biotechnology and pharmaceutical companies with a shared passion for developing innovative therapies for patients with unmet medical needs.